Participate in COVID-19 Research
Stanford Medicine scientists have launched many research projects, including clinical trials, as part of the global response to COVID-19. The projects listed below are currently enrolling participants. If you are interested in participating in these projects or other research efforts at Stanford Medicine, join the Stanford Medicine Research Registry.
Researchers at Stanford, U.C. San Francisco, and the Chan Zuckerberg Biohub are tracking changes in San Francisco Bay Area SARS-CoV-2 infection to understand how many people are currently infected, how likely it is someone will become infected, and the body’s immune response.
This daily health survey seeks to predict which geographical areas will be most impacted by coronavirus based on how you are feeling. This information will be used along with local test results to predict surges and severity of coronavirus by region and to inform local and national responses.
This study seeks to discover if information from wearable devices can help detect COVID-19 before symptoms emerge. For iOS users, the study supports Fitbit devices, Garmin devices, Samsung Galaxy Watch, Apple Watch, and Oura Ring. For Android users, it supports Fitbit devices.
The CHART study tracks SARS-CoV-2 infection and antibodies in health care works to understand immune response and infection over time. The goal of the CHART study is to inform strategies to keep our hospitals safe for patients and staff.
This is a single-blind, randomized trial of a 10-day course of favipiravir compared with placebo in outpatients who have been diagnosed with COVID-19 within the past 72 hours. Favipiravir works by blocking a viral enzyme that makes viral RNA, halting the virus’s ability to replicate itself.